In an interview, Martin Lange, Novos head of development, said he so far hasnt seen evidence of the drug affecting childrens growth and development, but our commitment is to investigate our drugs in all populations where we get approved, so that would be part of our commitment to continue to to assess that. Even before this new data on young children, experts were already conflicted on how to address obesity in teenagers
Highly processed foods, sugary drinks, or large amounts of unhealthy fats cause rapid spikes in blood sugar levels, which can override the effect of semaglutide and trigger hunger despite taking the medication
Key GLP1 therapies are integrated into national insurance schemes, and the countrys aging population underscores its strategic importance in diabetes and obesity management
Clinical studies highlight its efficacy, showing an average weight loss of 15% to 20% when paired with lifestyle adjustments